Sanaz Memarzadeh
- Molecular Biology top 10%
- Oncology top 5%
- Reproductive Medicine top 1%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Co-authors
- Owen N. WitteHong WuXin LiDeanna M. JanzenJiaoti HuangRita U. LukacsYang ZongRobin Farias‐Eisner
- Topics
- Ovarian cancer diagnosis and treatment (21 papers)Endometrial and Cervical Cancer Treatments (11 papers)Immune Cell Function and Interaction (8 papers)
- Journals
- Proceedings of the National Academy of SciencesNature CommunicationsJournal of Clinical Oncology
- Partner nations
- United StatesSpainCanada
In The Last Decade
Sanaz Memarzadeh
59 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.1k
- Oncology 918
- Reproductive Medicine 509
- Pulmonary and Respiratory Medicine 439
- Cancer Research 424
Countries citing papers authored by Sanaz Memarzadeh
This map shows the geographic impact of Sanaz Memarzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanaz Memarzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanaz Memarzadeh more than expected).
Fields of papers citing papers by Sanaz Memarzadeh
This network shows the impact of papers produced by Sanaz Memarzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanaz Memarzadeh. The network helps show where Sanaz Memarzadeh may publish in the future.
Co-authorship network of co-authors of Sanaz Memarzadeh
This figure shows the co-authorship network connecting the top 25 collaborators of Sanaz Memarzadeh. A scholar is included among the top collaborators of Sanaz Memarzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanaz Memarzadeh. Sanaz Memarzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancerbreakdown → | 81 |
| 4 | 14 | |
| 5 | 18 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 120 | |
| 9 | 7 | |
| 10 | 190 | |
| 11 | 30 | |
| 12 | 4 | |
| 13 | 58 | |
| 14 | 22 | |
| 15 | 34 | |
| 16 | 30 | |
| 17 | 47 | |
| 18 | 211 | |
| 19 | 81 | |
| 20 | 51 |
About Sanaz Memarzadeh
Sanaz Memarzadeh is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 60 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (11 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Reproductive Medicine (509 citations), Obstetrics and Gynecology (282 citations) and Oncology (918 citations). Sanaz Memarzadeh has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Owen N. Witte, Hong Wu, Xin Li, Deanna M. Janzen, Jiaoti Huang, Rita U. Lukacs, Yang Zong, Robin Farias‐Eisner, Alice Soragni and Devon A. Lawson. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.